Pro Medicus Limited (ASX:PME)

Australia flag Australia · Delayed Price · Currency is AUD
317.34
-0.35 (-0.11%)
Jul 11, 2025, 4:10 PM AEST
136.63%
Market Cap 33.15B
Revenue (ttm) 184.58M
Net Income (ttm) 98.29M
Shares Out 104.46M
EPS (ttm) 0.94
PE Ratio 337.27
Forward PE 242.11
Dividend 0.50 (0.16%)
Ex-Dividend Date Feb 27, 2025
Volume 183,247
Average Volume 191,136
Open 318.00
Previous Close 317.69
Day's Range 313.61 - 320.18
52-Week Range 121.21 - 325.00
Beta 0.44
RSI 77.63
Earnings Date Aug 14, 2025

About Pro Medicus

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu... [Read more]

Sector Healthcare
Founded 1983
Employees 69
Stock Exchange Australian Securities Exchange
Ticker Symbol PME
Full Company Profile

Financial Performance

In 2024, Pro Medicus's revenue was 161.50 million, an increase of 29.30% compared to the previous year's 124.90 million. Earnings were 82.79 million, an increase of 36.52%.

Financial Statements

News

ASX to rise; Wall St rallies; bitcoin tops $US112k

Shares open higher; property stocks rebound; Pro Medicus continues charge; CSL remains “undervalued”: Morningstar. Follow live.

1 day ago - The Australian Financial Review

Pro Medicus runs to $300 so fast investors can’t catch up

Whenever the healthcare imaging software group signs a new customer contract, fund managers hide under their desks. This latest one really hurts.

8 days ago - The Australian Financial Review

ASX flat as miners gain, but banks fall; all eyes on GemLife IPO

Shares fall; Pro Medicus cracks record; Japanese giants buy into Gold Hydrogen; Rio Tinto firm to invest $1.7b into Quebec facilities. Follow live.

8 days ago - The Australian Financial Review

Can billionaire Anthony Hall build the next great seafood business?

The businessman made his fortune in medical imaging giant Pro Medicus. He’s snapping up abalone producers, oyster farms and fisheries for his next venture.

3 months ago - The Australian Financial Review

Pro Medicus targets $894M forward revenue with expanded cloud-based deals and AI focus

Pro Medicus reports record Q2 2025 results with 31.1% revenue growth, $894M projected forward revenue, and strong U.S. penetration.

5 months ago - Seeking Alpha

ASX 200 LIVE: COH hikes dividend, shares slump; Donald Trump tariff plans fails to deter traders as sharemarket rises.

Shares lift; CBA sells off after shares peak; Pro Medicus upgraded; Cochlear, AMP down on profit blow; Mirvac earnings fall to 0¢; $A nears two-month high.

5 months ago - The Australian Financial Review

Pro Medicus Ltd (PMCUF) (Q1 2025) Earnings Call Highlights: Record Revenue Growth and Strategic ...

Pro Medicus Ltd (PMCUF) (Q1 2025) Earnings Call Highlights: Record Revenue Growth and Strategic Expansions

5 months ago - GuruFocus

Half Year 2025 Pro Medicus Ltd Earnings Call Transcript

Half Year 2025 Pro Medicus Ltd Earnings Call Transcript

5 months ago - GuruFocus

Pro Medicus billionaires in $500m sell-down

The trade crossed the screen in two lines on Tuesday afternoon, with about 2 million shares changing hands at last price.

7 months ago - The Australian Financial Review

Rocket stock Pro Medicus redefines what’s possible

The medical software company is the sort of investment that makes you glad your job does not decide on picking whether it is a market winner or loser.

8 months ago - The Australian Financial Review

Earnings-season surprises shake up ASX short sellers

Fortescue, Woodside Energy and Pro Medicus have topped the list of companies being bet against as hedge funds rework their strategies after reporting season.

11 months ago - The Australian Financial Review

Why tech bolters are lighting up reporting season

WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.

11 months ago - The Australian Financial Review

Pro Medicus share surge defies growth warning

Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be hard to maintain.

11 months ago - The Australian Financial Review

The five best-performing ASX 200 stocks this financial year

Healthcare software developer Pro Medicus narrowly bested family monitoring app Life360 to be the top-performing stock, with a 118.7 per cent return in 12 months.

1 year ago - The Australian Financial Review

The ASX business so good ‘you can’t put a sell on it’

Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.

1 year ago - The Australian Financial Review

Why Paradice is backing Seven Group’s bid for Boral

Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.

1 year ago - The Australian Financial Review

ASX PME:

A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.

1 year ago - The Australian Financial Review

Pro Medicus reports 1H results

1 year ago - Seeking Alpha

Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

The Aussies hoping to make a fortune from Apple’s Vision Pro

The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.

1 year ago - The Australian Financial Review

Pro Medicus founders in $176m selldown; Unified Capital nabs trade

Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.

1 year ago - The Australian Financial Review

Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript

Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confer...

2 years ago - Seeking Alpha